Lori Pinkley, a 50-year-old from Kansas City, Mo., has struggled with puzzling chronic pain since she was 15. She has had countless disappointing visits with doctors. Some said they couldn’t […]
Read more
US awards $3M to fill gaps in medical marijuana research
The U.S. government is spending $3 million to find out if marijuana can relieve pain, but none of the money will be used to study the part of the plant […]
Read more
Preference for fentanyl higher amount young, white, frequent opioid users
A minority of people who use illicit opioids indicated a preference for fentanyl, the super-potent synthetic opioid that accounts for much of the recent rise in U.S. overdose deaths, according […]
Read more
Scientists prove low cost arthritis drug can effectively treat blood cancer sufferers
A simple arthritis drug could be an effective, low cost solution to treat patients with blood cancers such as polycythemia vera (PV) and essential thrombocythemia (ET), a breakthrough study by […]
Read more
Antibiotic usage associated with increased risk of rheumatoid arthritis
A new study has provided evidence that antibiotic usage is associated with an increased risk of developing rheumatoid arthritis. Researchers from Keele University and the Quadram Institute analysed data from […]
Read more
With opioid abuse surging, expert panel recommends drug screening for all US adults
It’s time for doctors to start asking every patient, every time: Have you engaged in any illicit drug use? That’s the new advice from a panel of public health experts […]
Read more
Weakly regulated painkillers are causing untold damage in West Africa
Ayao* is a tall and well-built 15-year-old, and like many his age, he is very particular about his appearance. He wears a white T-shirt with a colourful design on the […]
Read more
Rituximab noninferior to cyclosporine in membranous nephropathy
(HealthDay)—In patients with membranous nephropathy at high risk for progressive disease, rituximab is noninferior to cyclosporine in inducing complete or partial remission of proteinuria at 12 months and is superior […]
Read more
No evidence of added benefit for most new drugs, say researchers
More than half of new drugs entering the German healthcare system have not been shown to add benefit, argue researchers in The BMJ today. Beate Wieseler and colleagues at the […]
Read more
Eye drops, ointments sold at Walgreens recalled
(HealthDay)—A number of over-the-counter eye products sold at Walgreens have been recalled by manufacturer Altaire Pharmaceuticals because the products may not be sterile. The use of nonsterile products could result […]
Read more